Terms: = Head and neck cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
20 results:
1. Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Rezaei N
PLoS One; 2023; 18(9):e0291921. PubMed ID: 37733767
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA malat1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
3. Mechanism of METTL14 and m6A modification of lncRNA malat1 in the proliferation of oral squamous cell carcinoma cells.
Li J; Momen-Heravi F; Wu X; He K
Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
[TBL] [Abstract] [Full Text] [Related]
4. Epithelioid Soft Tissue Neoplasm of the Soft Palate with a PTCH1-GLI1 Fusion: A Case Report and Review of the Literature.
Klubíčková N; Kinkor Z; Michal M; Baněčková M; Hájková V; Michálek J; Pink R; Dvořák Z; Michal M; Leivo I; Skálová A
Head Neck Pathol; 2022 Jun; 16(2):621-630. PubMed ID: 34655412
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA malat1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis.
Dai J; Zhou N; Wu R; Du J; Miao S; Gong K; Yang L; Chen W; Li X; Li C; Wu Y
Pathol Oncol Res; 2021; 27():610159. PubMed ID: 34257576
[TBL] [Abstract] [Full Text] [Related]
6. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (malat1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma.
Yu L; Shao X; Huo L; Zhang T
Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299
[TBL] [Abstract] [Full Text] [Related]
7. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
8. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
[TBL] [Abstract] [Full Text] [Related]
9. Long noncoding RNA malat1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
Yao Q; Yang J; Liu T; Zhang J; Zheng Y
FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
[TBL] [Abstract] [Full Text] [Related]
10. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract] [Full Text] [Related]
11. Long Non-Coding RNAs in Thyroid cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA malat1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.
Hardin H; Helein H; Meyer K; Robertson S; Zhang R; Zhong W; Lloyd RV
Lab Invest; 2018 Sep; 98(9):1133-1142. PubMed ID: 29967342
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA malat1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract] [Full Text] [Related]
15. Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review.
Sannigrahi MK; Sharma R; Panda NK; Khullar M
Oral Dis; 2018 Nov; 24(8):1417-1427. PubMed ID: 28941018
[TBL] [Abstract] [Full Text] [Related]
16. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract] [Full Text] [Related]
17. Serum long non-coding RNAs malat1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.
He B; Zeng J; Chao W; Chen X; Huang Y; Deng K; Huang Z; Li J; Dai M; Chen S; Huang H; Dai S
Oncotarget; 2017 Jun; 8(25):41166-41177. PubMed ID: 28467811
[TBL] [Abstract] [Full Text] [Related]
18. Long noncoding RNA malat1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.
Li Z; Zhou Y; Tu B; Bu Y; Liu A; Kong J
J Oral Pathol Med; 2017 Sep; 46(8):583-590. PubMed ID: 27935117
[TBL] [Abstract] [Full Text] [Related]
19. Long noncoding RNA malat1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
[TBL] [Abstract] [Full Text] [Related]
20. Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma.
Chen H; Xin Y; Zhou L; Huang JM; Tao L; Cheng L; Tian J
Med Oncol; 2014 Nov; 31(11):246. PubMed ID: 25257554
[TBL] [Abstract] [Full Text] [Related]
